Fibrogen Inc. sell Bank of America Co.
Start price
08.08.23
/
50%
€1.55
Target price
08.08.24
€1.83
Performance (%)
-28.97%
Price
21.05.24
€1.10
Summary
This prediction is currently active. The price of Fibrogen Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -28.97%. This prediction currently runs until 08.08.24. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Fibrogen Inc. | 0.228% | 0.228% |
iShares Core DAX® | -1.347% | 3.576% |
iShares Nasdaq 100 | 1.169% | 7.020% |
iShares Nikkei 225® | -0.327% | -0.673% |
iShares S&P 500 | 0.510% | 4.445% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Fibrogen Inc. diskutieren
FibroGen, Inc. (NASDAQ: FGEN) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating. They now have a $2.00 price target on the stock, down previously from $4.00.
Ratings data for FGEN provided by MarketBeat